Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thorsten Schlomm

Showing results (121-130 of 359) with videos related to

Pageof 36
Sort By:
World Journal of Urology|May 14, 2014
A comparative assessment of active surveillance for localized prostate cancer in the community versus tertiary care referral centerAndreas Becker, Daniel Seiler, Maciej Kwiatkowski, et al.
Journal of Clinical Medicine|October 9, 2019
Native Nephrectomy before and after Renal Transplantation in Patients with Autosomal Dominant Polycystic Kidney Disease (ADPKD)Andreas Maxeiner, Anna Bichmann, Natalie Oberländer, et al.
Microarrays (Basel, Switzerland)|September 8, 2016
Qualitative and Quantitative Requirements for Assessing Prognostic Markers in Prostate CancerChristoph Burdelski, Aleksandra Matuszewska, Martina Kluth, et al.
Cancers|July 12, 2025
De Novo Renal Cell Carcinoma in Kidney Transplant Recipients: Incidence, Outcomes, and Therapeutic ChallengesJacob Schmidt, Malte Lehnert, Isabel Lichy, et al.
Oncotarget|December 20, 2015
Heterogeneity and chronology of 6q15 deletion and ERG-fusion in prostate cancerMartina Kluth, David Meyer, Antje Krohn, et al.
BJU International|February 26, 2015
Salvage radical prostatectomy for recurrent prostate cancer: verification of European Association of Urology guideline criteriaPhilipp Mandel, Thomas Steuber, Sascha Ahyai, et al.
BJU International|April 24, 2012
Risk assessment of metastatic recurrence in patients with prostate cancer by using the Cancer of the Prostate Risk Assessment score: results from 2937 European patientsLars Budäus, Hendrik Isbarn, Pierre Tennstedt, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|August 18, 2012
Marked heterogeneity of ERG expression in large primary prostate cancersSarah Minner, Michael Gärtner, Fabian Freudenthaler, et al.
BJU International|August 14, 2012
Accuracy of HistoScanning™ for the prediction of a negative surgical margin in patients undergoing radical prostatectomyGeorg Salomon, Jan Spethmann, Ann Beckmann, et al.
The Prostate|September 30, 2011
Y chromosome losses are exceedingly rare in prostate cancer and unrelated to patient agePhillip R Stahl, Adisa Kilgué, Pierre Tennstedt, et al.
Pageof 36

Showing results (121-130 of 359) with videos related to

Sort By:
Pageof 36
World Journal of Urology|May 14, 2014
A comparative assessment of active surveillance for localized prostate cancer in the community versus tertiary care referral centerAndreas Becker, Daniel Seiler, Maciej Kwiatkowski, et al.
Journal of Clinical Medicine|October 9, 2019
Native Nephrectomy before and after Renal Transplantation in Patients with Autosomal Dominant Polycystic Kidney Disease (ADPKD)Andreas Maxeiner, Anna Bichmann, Natalie Oberländer, et al.
Microarrays (Basel, Switzerland)|September 8, 2016
Qualitative and Quantitative Requirements for Assessing Prognostic Markers in Prostate CancerChristoph Burdelski, Aleksandra Matuszewska, Martina Kluth, et al.
Cancers|July 12, 2025
De Novo Renal Cell Carcinoma in Kidney Transplant Recipients: Incidence, Outcomes, and Therapeutic ChallengesJacob Schmidt, Malte Lehnert, Isabel Lichy, et al.
Oncotarget|December 20, 2015
Heterogeneity and chronology of 6q15 deletion and ERG-fusion in prostate cancerMartina Kluth, David Meyer, Antje Krohn, et al.
BJU International|February 26, 2015
Salvage radical prostatectomy for recurrent prostate cancer: verification of European Association of Urology guideline criteriaPhilipp Mandel, Thomas Steuber, Sascha Ahyai, et al.
BJU International|April 24, 2012
Risk assessment of metastatic recurrence in patients with prostate cancer by using the Cancer of the Prostate Risk Assessment score: results from 2937 European patientsLars Budäus, Hendrik Isbarn, Pierre Tennstedt, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|August 18, 2012
Marked heterogeneity of ERG expression in large primary prostate cancersSarah Minner, Michael Gärtner, Fabian Freudenthaler, et al.
BJU International|August 14, 2012
Accuracy of HistoScanning™ for the prediction of a negative surgical margin in patients undergoing radical prostatectomyGeorg Salomon, Jan Spethmann, Ann Beckmann, et al.
The Prostate|September 30, 2011
Y chromosome losses are exceedingly rare in prostate cancer and unrelated to patient agePhillip R Stahl, Adisa Kilgué, Pierre Tennstedt, et al.
Pageof 36